Abstract:OBJECTIVE:To explore the possible mechanisms of cell apoptosis induced by arsenic trioxide (ATO) alone or in combination with thalidomide (THAL) on SCID mice model transplanted with human myelodysplastic syndrome (MDS) cell line MUTZ-1 in vivo.METHODS:In a previous study by the authors, a Hum-MDS mice model was successfully established and the results showed that ATO alone or in combination with THAL had markedly inhibitory effect on the tumors growth in the MDS mice model of the treated groups with higher-rates of cell apoptosis and longer-survival periods than control groups (P < 0.01). In the present study, 48 Hum-MDS mice were randomly grouped and ATO groups had 32 mice which were treated with ATO [5.0 microg or 7.5 microg/(g.d), 5 d a week, intraperitoneal injection (i.p.) x 3 weeks alone or in combination with THAL 8 microg/(g.d) x 3 weeks] and the control groups had 16 mice [treated with 0.9% NaCl 10 microl/(g.d) (i.p) or untreated]. The expressions of the proteins and the genes related to apoptosis were detected by using immunohistochemical (IHC) method, Western blot, reverse transcription-polymerase chain reaction (RT-PCR), electrophoretic mobility shift assay (EMSA) with [gamma-32P] ATP oligonucleotide probe end labeling.RESULTS:(1) By IHC, compared to controls, the expressions of the pro-apoptosis protein Bax (F = 1080.150, P < 0.01) and the ratio of Bax/Bcl-2 were higher, but Bcl-2 (F = 2777.978, P < 0.01) was lower in the treated groups. (2) Western-blot results showed that the pro-apoptosis protein expressions of mitochondrial Smac/DIABLO and cytochrome C (IHC) were strikingly up-regulated and pro-caspase 9, 7, 6, 3 and full PARP were down-regulated and cleaved caspase-6, 7, 9 and PARP were clearly observed in the treated groups. The expressions of apoptosis protein inhibitors of cIAP1 and survivin mRNA (RT-PCR) were markedly down-regulated in the treated groups. But no evidences of cleavage of BID and caspase-8 had been observed in any group. (3) The expression of IkappaB-alpha protein [nuclear factor-kappa B (NF-kappaB) inhibitor] was up-regulated (Western-blot) and the activity of NF-kappaB were sharply down-regulated in ATO-treated groups by EMSA.CONCLUSIONS:These results suggest that mitochondria are the primary intracellular target of ATO. At least, two pathways, namely, mitochondrial mediated-caspase dependent cell apoptosis pathway and NF-kappaB signal conduct pathway were involved in the mechanisms of ATO inducing cell apoptosis on MDS mice model in vivo. The mechanisms seem to be a complicated network regulated by multi-signal pathways, multi-layers, and multi-factors instead of a single pathway.

Hypoxia Inducible Factor-1Alpha and Leukemic Cell Differentiation.

Hypoxia-simulating Agents and Selective Stimulation of Arsenic Trioxide-Induced Growth Arrest and Cell Differentiation in Acute Promyelocytic Leukemic Cells.

Mechanisms of Arsenic Trioxide Induced Tumor Cell Apoptosis in Myelodysplastic Syndrome Mice Model in Vivo

Arsenic Trioxide Induces Not Only Apoptosis but Also Autophagic Cell Death in Leukemia Cell Lines Via Up-Regulation of Beclin-1

Arsenic Trioxide Replacing or Reducing Chemotherapy in Consolidation Therapy for Acute Promyelocytic Leukemia (APL2012 Trial)

Arsenic Trioxide-Induced Apoptosis and Differentiation Are Associated Respectively with Mitochondrial Transmembrane Potential Collapse and Retinoic Acid Signaling Pathways in Acute Promyelocytic Leukemia

Hypoxia-HIF-1α-C/EBPα/Runx1 signaling in leukemic cell differentiation

Cobalt Chloride and Low Oxygen Tension Trigger Differentiation of Acute Myeloid Leukemic Cells: Possible Mediation of Hypoxia-Inducible Factor-1Α

Balance Between the Toxicity and Anticancer Activity of Arsenic Trioxide in Treatment of Acute Promyelocytic Leukemia.

Hypoxia-inducible Factor-1Α-induced Differentiation of Myeloid Leukemic Cells is Its Transcriptional Activity Independent

Arsenic trioxide, a therapeutic agent for APL.

Synergic Effects of Arsenic Trioxide and Camp During Acute Promyelocytic Leukemia Cell Maturation Subtends a Novel Signaling Cross-Talk

Hypoxia, Hypoxia-Inducing Factor-1 and Leukemic Cell Differentiation

Arsenic Trioxide (ato) Downregulates the Expression of the Aml1/Mds1/Evi-1 (ame) Oncoprotein and Induces Differentiation and Apoptosis in Ame-Leukemic Cells

Induction Of Tumor Arrest And Differentiation With Prolonged Survival By Intermittent Hypoxia In A Mouse Model Of Acute Myeloid Leukemia

Treatment of Acute Promyelocytic Leukemia with ATRA and As2O3: a Model of Molecular Target-Based Cancer Therapy.

Active Compounds-Based Discoveries about the Differentiation and Apoptosis of Leukemic Cells

Arsenic trioxide induces differentiation of cancer stem cells in hepatocellular carcinoma through inhibition of LIF/JAK1/STAT3 and NF‐kB signaling pathways synergistically

Interaction between arsenic trioxide and human primary cells: emphasis on human cells of myeloid origin

Arsenic Trioxide Induces Apoptosis in the THP1 Cell Line by Downregulating EVI-1

A Model of Molecular Target-Based Cancer Therapy